You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting

ID: 12-14 mai 2012
Type of Content: Guidelines & Advice, Evidence Summary
Document Status: Current
Authors:
V. Kukreti, R. Cosby, A. Cheung, S. Lankshear, ST CPOE Guideline Development Group

Research Question(s)

Global Question

  • What are the features, functions and components of a Systemic Therapy (ST) Computerized Prescriber Order Entry (CPOE) system that are required to ensure safe, highquality systemic treatment?

Specific Questions

  1. Does ST CPOE decrease medication errors in chemotherapy prescribing compared to usual practice, and if so, what types of errors does it decrease?
  2. Does ST CPOE generate new errors, and if so, what types of new errors does it increase?
  3. What is the impact of ST CPOE on practice (e.g., workflow, workload, team communication)?
  4. What are the strategies that enhance or limit implementation of ST CPOE?
  5. What types of clinical decision supports are available, and are they effective or ineffective?
pdf download Summary (PDF) (1.57 Mo)
pdf download Full Report (PDF) (562.49 Ko)